Atosiban and Rutin exhibit anti-mycobacterial activity - An integrated computational and biophysical insight toward drug repurposing strategy against Mycobacterium tuberculosis targeting its essential enzyme HemD-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Atosiban and Rutin exhibit anti-mycobacterial activity - An integrated computational and biophysical insight toward drug repurposing strategy against Mycobacterium tuberculosis targeting its essential enzyme HemD

Published:2023-12 Issue: Volume:253 Page:127208
ISSN:0141-8130
Container-title:International Journal of Biological Macromolecules
language:en
Short-container-title:International Journal of Biological Macromolecules

Author:

Sharma Rahul,Muthu Shivani A.,Agarwal Meetu,Mehto Naveen Kumar,Pahuja Isha,Grover Abhinav,Dwivedi Ved Prakash,Ahmad Basir,Grover Sonam

Publisher

Elsevier BV

Subject

Molecular Biology,General Medicine,Biochemistry,Structural Biology

Reference74 articles.

1. A tale of two global emergencies: tuberculosis control efforts can learn from the Ebola outbreak;Nathavitharana;Eur. Respir. J.,2015

2. The WHO Global Tuberculosis 2021 Report – not so good news and turning the tide back to End TB;Jeremiah;Int. J. Infect. Dis.,2022

3. Tuberculosis and HIV co-infection;Pawlowski;PLoS Pathog.,2012

4. From magic bullets back to the Magic Mountain: the rise of extensively drug-resistant tuberculosis;Dorman;Nat. Med.,2007

5. Bedaquiline in the treatment of multidrug- and extensively drug-resistant tuberculosis;Pym;Eur. Respir. J.,2016

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unravelling the potential of Triflusal as an anti-TB repurposed drug by targeting replication protein DciA;Microbes and Infection;2023-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP